Ascendis Pharma Receivables 2015-2024 | ASND

Ascendis Pharma receivables for the quarter ending September 30, 2024 were $0.055B, a 1.67% increase year-over-year.

  • Ascendis Pharma receivables for 2023 were $0.06B, a 123.57% increase from 2022.
  • Ascendis Pharma receivables for 2022 were $0.027B, a 1.57% decline from 2021.
  • Ascendis Pharma receivables for 2021 were $0.027B, a 226.99% increase from 2020.

Ascendis Pharma Receivables 2015-2024 | ASND

  • Ascendis Pharma receivables for 2023 were $0.06B, a 123.57% increase from 2022.
  • Ascendis Pharma receivables for 2022 were $0.027B, a 1.57% decline from 2021.
  • Ascendis Pharma receivables for 2021 were $0.027B, a 226.99% increase from 2020.